1. Integrative Oncology’s 30-Year Anniversary: What Have We Achieved? A North American Naturopathic Oncology Perspective
   Leanna J. Standish et al, 2023, Integrative Cancer Therapies CrossRef
2. Plant leads for mitigation of oral submucous fibrosis: Current scenario and future prospect
   Sarita Pal et al, 2024, Oral Diseases CrossRef
3. Potential applications of polyphenols on main ncRNAs regulations as novel therapeutic strategy for cancer
   Juanjuan Yi et al, 2019, Biomedicine & Pharmacotherapy CrossRef
4. Delivery system of phenolic compounds for the treatment of lung cancer
   Akhileshwar Kumar Srivastava et al, 2024, Drug-delivery Systems of Phytochemicals and Therapeutic Strategies in Cancer Therapy CrossRef
5. Aryl hydrocarbon receptor dynamics in esophageal squamous cell carcinoma: From immune modulation to therapeutic opportunities
   Mina Rahmati et al, 2024, World Journal of Experimental Medicine CrossRef
6. Systems pharmacology investigation of mechanism of action of nutraceuticals
   Dimitris E. Messinis et al, 2021, Nutraceuticals CrossRef
7. Resveratrol Effects on Molecular Pathways and MicroRNAs in Gastrointestinal Cancers
   Amirhossein Davoodvandi et al, 2023, Current Medicinal Chemistry CrossRef
8. Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
   Mengqiu Song et al, 2024, Molecular Carcinogenesis CrossRef
9. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases
   Xia Yang et al, 2020, Phytomedicine CrossRef
10. Novel Drug Combinations in Lung Cancer: New Potential Synergies Between 5-FU and Repurposed Drugs
    Eduarda Ribeiro et al, 2024, Applied Sciences CrossRef
11. Applications of resveratrol in the treatment of gastrointestinal cancer
    Mohammad Roshani et al, 2022, Biomedicine & Pharmacotherapy CrossRef
12. Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
    Rakesh E. Mutha et al, 2021, Future Journal of Pharmaceutical Sciences CrossRef
13. The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens
    Eduarda Ribeiro et al, 2024, Targets CrossRef
14. Resveratrol as sensitizer in colorectal cancer plasticity
    Aranka Brockmueller et al, 2024, Cancer and Metastasis Reviews CrossRef
15. Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma
    Xuan Hong et al, 2023, Journal of Biological Chemistry CrossRef
16. Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression
    Jinhua Wang et al, 2022, International Journal of Molecular Sciences CrossRef
17. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight
    Rutuja Damare et al, 2024, Phytotherapy Research CrossRef